Mark van Oene
Chief Operating Officer chez PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Fortune : 6 M $ au 31/03/2024
Profil
Mark David Van Oene occupe le poste de directeur de l'exploitation chez Pacific Biosciences of California, Inc. Il est également membre du conseil d'administration de BlueGnome Ltd. et d'Illumina Cambridge Ltd. Il était auparavant directeur commercial et vice-président principal chez Illumina, Inc. et directeur des services de génotypage chez Ellipsis Biotherapeutics Corp. Il a obtenu un diplôme de premier cycle à l'Université de Western Ontario et un doctorat à l'Université de Toronto.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 04/03/2024 | 1 668 826 ( 0,61% ) | 6 M $ | 31/03/2024 |
Postes actifs de Mark van Oene
| Sociétés | Poste | Début |
|---|---|---|
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | Chief Operating Officer | 08/01/2021 |
Illumina Cambridge Ltd.
 Illumina Cambridge Ltd. Miscellaneous Commercial ServicesCommercial Services Illumina Cambridge Ltd. develops, manufactures and commercializes instruments, consumables and technologies for the analysis of DNA and genetic variation. The company was founded in 1998 and is headquartered in Saffron Walden, the United Kingdom. | Director/Board Member | - |
BlueGnome Ltd.
 BlueGnome Ltd. Packaged SoftwareTechnology Services BlueGnome Ltd. provides application software services. It offers solutions for detection of copy number variation in the human genome. The firm's main application areas include analysis of constitutional samples to elucidate genetic disease, investigation of haematological malignancies and aneuploidy screening of single cells. The company was founded on October 15, 2001 and is headquartered in Saffron Walden, the United Kingdom. | Director/Board Member | 22/01/2018 |
Dante Labs, Inc.
 Dante Labs, Inc. Medical/Nursing ServicesHealth Services Dante Labs, Inc. operates as a genetic testing laboratory. The company was founded by Andrea Riposati and Mattia Capulli in 2016 and is headquartered in New York, NY. | Director/Board Member | 24/08/2021 |
Anciens postes connus de Mark van Oene
| Sociétés | Poste | Fin |
|---|---|---|
Ellipsis Biotherapeutics Corp.
 Ellipsis Biotherapeutics Corp. Miscellaneous Commercial ServicesCommercial Services Part of DNAPrint Genomics, Inc., Ellipsis Biotherapeutics Corp. provides commercial genotyping services and gene research. The private company is based in Toronto, Canada. Ellipsis Biotherapeutics was acquired by DNAPrint Genomics, Inc. on December 19, 2005 for $0.11 million. | Corporate Officer/Principal | - |
| ILLUMINA, INC. | Corporate Officer/Principal | - |
Formation de Mark van Oene
| University of Toronto | Doctorate Degree |
| University of Western Ontario | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| ILLUMINA, INC. | Health Technology |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | Health Technology |
| Entreprise privées | 4 |
|---|---|
BlueGnome Ltd.
BlueGnome Ltd. Packaged SoftwareTechnology Services BlueGnome Ltd. provides application software services. It offers solutions for detection of copy number variation in the human genome. The firm's main application areas include analysis of constitutional samples to elucidate genetic disease, investigation of haematological malignancies and aneuploidy screening of single cells. The company was founded on October 15, 2001 and is headquartered in Saffron Walden, the United Kingdom. | Technology Services |
Ellipsis Biotherapeutics Corp.
Ellipsis Biotherapeutics Corp. Miscellaneous Commercial ServicesCommercial Services Part of DNAPrint Genomics, Inc., Ellipsis Biotherapeutics Corp. provides commercial genotyping services and gene research. The private company is based in Toronto, Canada. Ellipsis Biotherapeutics was acquired by DNAPrint Genomics, Inc. on December 19, 2005 for $0.11 million. | Commercial Services |
Dante Labs, Inc.
Dante Labs, Inc. Medical/Nursing ServicesHealth Services Dante Labs, Inc. operates as a genetic testing laboratory. The company was founded by Andrea Riposati and Mattia Capulli in 2016 and is headquartered in New York, NY. | Health Services |
Illumina Cambridge Ltd.
Illumina Cambridge Ltd. Miscellaneous Commercial ServicesCommercial Services Illumina Cambridge Ltd. develops, manufactures and commercializes instruments, consumables and technologies for the analysis of DNA and genetic variation. The company was founded in 1998 and is headquartered in Saffron Walden, the United Kingdom. | Commercial Services |
